Bellerophon Therapeutics (United States)

A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis

Steven D. Nathan, Kevin R. Flaherty, Marilyn K. Glassberg et al. · CHEST Journal · 2020 · 106 citations

Medicine, Clinical Sciences, Internal Medicine +12

Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction

Sunil V. Rao, Uwe Zeymer, Pamela S. Douglas et al. · Journal of the American College of Cardiology · 2016 · 100 citations

Medicine, Biomedical Engineering, Cardiology +16

A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen

Annals of the American Thoracic Society · 2021 · 47 citations

Medicine, Clinical Sciences, Internal Medicine +16

A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial

Sunil V. Rao, Uwe Zeymer, Pamela S. Douglas et al. · American Heart Journal · 2015 · 45 citations

Medicine, Cardiology, Internal Medicine +12

Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension

Bita Hajian, Jan De Backer, Wim Vos et al. · International Journal of COPD · 2016 · 42 citations · Full text

Medicine, Radiology, Diagnostic Imaging +16